Neurology: Volume 92, Number 13, March 26, 2019 Exam #2 - A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score

About this course

  • Released: 03/26/2019
  • Expires: 03/26/2022


A NOVEL BIOMARKER-BASED PROGNOSTIC SCORE IN ACUTE ISCHEMIC STROKE: THE CORISK SCORE

LEARNING OBJECTIVES:

Upon completion of the article by De Marchis et al, the participant should be able to:

  • State the ability of the CoRisk score to effectively predict 3-month functional outcomes in patients with acute ischemic stroke found in this study
  • Describe the predictive model performance of the CoRisk score in this study, specifically how the inclusion of copeptin values changed area under the curve values and the proportion of patients whose final predicted outcome was reclassified
  • Discuss the ability of the CoRisk score to effectively predict 3-month mortality in patients with acute ischemic stroke described in this study


CORE COMPETENCIES:

The article by De Marchis et al covers the following core competency:

  • Medical Knowledge


AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.
 

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME